March 14, 2011, Osaka, Japan --- Takeda Pharmaceutical Company Limited (“Takeda”) today announced 300 million Japanese yen donation to aid emergency relief for the earthquake on March 11, through The Japanese Red Cross Society, in view of the huge damages in the wide geographical area affected in prefectures such as Iwate, Miyagi, Fukushima and others.
In addition to the cash donation aforementioned, Takeda is planning the donation of pharmaceutical products (both ethical and over-the-counter) and all other supports that are feasible for the Company.
We would like to express heartfelt condolences to the families of the victims, and we also sincerely wish the safety of the people affected by this earthquake and the earliest possible recovery of the relevant region.
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.